Tatiana Yu Astakhova Selected Research

Butyrylcholinesterase

1/2023	Derivatives of 9-phosphorylated acridine as butyrylcholinesterase inhibitors with antioxidant activity and the ability to inhibit β-amyloid self-aggregation: potential therapeutic agents for Alzheimer's disease.
8/2020	New Hybrids of 4-Amino-2,3-polymethylene-quinoline and p-Tolylsulfonamide as Dual Inhibitors of Acetyl- and Butyrylcholinesterase and Potential Multifunctional Agents for Alzheimer's Disease Treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatiana Yu Astakhova Research Topics

Disease

3	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 08/2020

Drug/Important Bio-Agent (IBA)

2	ButyrylcholinesteraseIBA 01/2023 - 08/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	AntioxidantsIBA 01/2023
1	AcridinesIBA 01/2023
1	ThioureaIBA 02/2022
1	thiophosgeneIBA 02/2022
1	amiridine (ipidacrine)IBA 02/2022
1	ChloridesIBA 02/2022
1	chloroacetic acid (chloroacetate)IBA 02/2022